<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.1//EN" "ep-patent-document-v1-1.dtd">
<ep-patent-document id="EP00965898B8W1" file="EP00965898W1B8.xml" lang="en" country="EP" doc-number="1212081" kind="B8" correction-code="W1" date-publ="20051228" status="c" dtd-version="ep-patent-document-v1-1">
<SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYAL..............................</B001EP><B003EP>*</B003EP><B005EP>J</B005EP><B007EP>DIM350 (Ver 2.1 Jan 2001)
 2999001/0</B007EP></eptags></B000><B100><B110>1212081</B110><B120><B121>CORRECTED EUROPEAN PATENT SPECIFICATION</B121></B120><B130>B8</B130><B132EP>B1</B132EP><B140><date>20051228</date></B140><B150><B151>W1</B151><B152><date>00000000</date></B152><B153>73</B153><B155><B1551>DE</B1551><B1552>Bibliographie</B1552><B1551>EN</B1551><B1552>Bibliography</B1552><B1551>FR</B1551><B1552>Bibliographie</B1552></B155></B150><B190>EP</B190></B100><B200><B210>00965898.0</B210><B220><date>20000825</date></B220><B240><B241><date>20020909</date></B241><B242><date>20021104</date></B242></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>9903028</B310><B320><date>19990827</date></B320><B330><ctry>SE</ctry></B330></B300><B400><B405><date>20051228</date><bnum>200552</bnum></B405><B430><date>20020612</date><bnum>200224</bnum></B430><B450><date>20051026</date><bnum>200543</bnum></B450><B452EP><date>20050411</date></B452EP><B480><date>20051228</date><bnum>200552</bnum></B480></B400><B500><B510><B516>7</B516><B511> 7A 61K  38/55   A</B511><B512> 7A 61K  31/00   B</B512><B512> 7A 61K  31/4184 B</B512><B512> 7A 61P   9/04   B</B512><B512> 7A 61P   9/10   B</B512><B512> 7A 61P   3/10   B</B512></B510><B540><B541>de</B541><B542>VERWENDUNG VON ACE INHIBITOREN ZUR PROPHYLAXE VON KONGESTIVEM HERZVERSAGEN</B542><B541>en</B541><B542>USE OF ACE INHIBITORS IN THE PREVENTION OF CONGESTIVE HEART FAILURE</B542><B541>fr</B541><B542>UTILISATIONS DES INHIBITEURS DE L'ENZYME DE CONVERSION DE L'ANGIOTENSINE POUR PREVENIR L'INSUFFISANCE CARDIAQUE GLOBALE</B542></B540><B560><B561><text>EP-A- 0 241 201</text></B561><B561><text>EP-A- 0 331 014</text></B561><B561><text>EP-A- 0 426 066</text></B561><B561><text>EP-A- 0 474 438</text></B561><B561><text>EP-A- 0 540 209</text></B561><B561><text>EP-A- 0 747 050</text></B561><B561><text>EP-A- 0 795 327</text></B561><B561><text>WO-A-00/02543</text></B561><B561><text>WO-A-00/71751</text></B561><B561><text>WO-A-01/15674</text></B561><B561><text>WO-A-93/20839</text></B561><B561><text>WO-A-96/24373</text></B561><B561><text>WO-A-97/27745</text></B561><B561><text>WO-A-97/49392</text></B561><B561><text>WO-A-98/30216</text></B561><B561><text>WO-A-99/20260</text></B561><B561><text>WO-A-99/44590</text></B561><B561><text>DE-A- 4 308 504</text></B561><B561><text>DE-A- 19 913 528</text></B561><B561><text>GB-A- 2 308 064</text></B561><B561><text>US-A- 5 190 970</text></B561><B561><text>US-A- 5 266 583</text></B561><B561><text>US-A- 5 308 846</text></B561><B561><text>US-A- 5 506 361</text></B561><B562><text>DATABASE WPI Week 199944 Derwent Publications Ltd., London, GB; AN 1999-520858 XP002166044 MASUDA YOSHINOBU, HONDA YAYOI, MINATO HISAO: "Inhibitor of cerebral vasospasm" &amp; JP 11 222439 A (DAINIPPON PHARM CO LTD), 17 August 1999 (1999-08-17)</text></B562><B562><text>OGIKU N ET AL: "Prophylactic effect of imidapril on stroke in stroke -prone spontaneously hypertensive rats." STROKE, (1993 FEB) 24 (2) 245-52., XP000997781</text></B562><B562><text>STIER C T JR ET AL: "ENALAPRIL PREVENTS STROKE AND KIDNEY DYSFUNCTION IN SALT-LOADED STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS" HYPERTENSION (DALLAS), vol. 13, no. 2, 1989, pages 115-121, XP000997775 ISSN: 0194-911X</text></B562><B562><text>ROBERT MKW LEE, HONG WANG, JOHN S SMEDA: "Effects of perindopril on hypertension and stroke prevention in experimental animals" CAN. J. CARDIOL., vol. 10, no. Suppl D, November 1994 (1994-11), pages 33D-36D, XP000998206</text></B562><B562><text>J.E.F. REYNOLDS: "Martindale The Extra Pharmacopoeia" 1996 , ROYAL PHARMACEUTICAL SOCIETY , LONDON XP002166043 page 863, column 2 -page 864, column 2 page 899, column 3 -page 900, column 1 page 940, column 3 -page 941, column 1</text></B562><B562><text>EBERHARDT ROBERT T ET AL: "Angiotensin II receptor blockade: An innovative approach to cardiovascular pharmacotherapy." JOURNAL OF CLINICAL PHARMACOLOGY, vol. 33, no. 11, 1993, pages 1023-1038, XP001019614 ISSN: 0091-2700</text></B562><B562><text>STIER CHARLES T JR ET AL: "Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats." JOURNAL OF HYPERTENSION, vol. 11, no. SUPPL. 3, 1993, pages S37-S42, XP001019687 Meeting on Losartan: An Orally Active Angiotensin II Antagonist;St. Paul de Vence, France; June 26-27, 1992 ISSN: 0263-6352</text></B562><B562><text>BLUMENTHAL MEL: "Treatment of congestive heart failure: Experience with fosinopril." AMERICAN JOURNAL OF HYPERTENSION, vol. 10, no. 10 PART 2, 1997, pages 289S-298S, XP001019673 ISSN: 0895-7061</text></B562><B562><text>NAKAMURA FUMIAKI ET AL: "Chronic administration of angiotensin II receptor antagonist, TCV-116, in cardiomyopathic hamsters." AMERICAN JOURNAL OF PHYSIOLOGY, vol. 267, no. 6 PART 2, 1994, pages H2297-H2304, XP001019610 ISSN: 0002-9513</text></B562><B562><text>K. PARFITT: "Martindale - The complete drug reference - Thirty-second Edition" 1999 , PHARMACEUTICAL PRESS , LONDON UK XP002176301 page 836, column 1 page 865, column 3 page 891, column 3 -page 892, column 1 page 899, column 1 page 951, column 3 page 960, column 2 -column 3</text></B562></B560></B500><B600><B620EP><parent><cdoc><dnum><anum>04006330.7</anum><pnum>1437131</pnum></dnum><date>20040317</date></cdoc></parent></B620EP></B600><B700><B720><B721><snm>SCHOELKENS, Bernward</snm><adr><str>Hölderlinstrasse 62</str><city>65779 Kelkheim</city><ctry>DE</ctry></adr></B721><B721><snm>BENDER, Norbert</snm><adr><str>Rheingaustrasse 26</str><city>65719 Hofheim</city><ctry>DE</ctry></adr></B721><B721><snm>RANGOONWALA, Badrudin</snm><adr><str>Dahlienweg 11</str><city>65719 Hofheim</city><ctry>DE</ctry></adr></B721><B721><snm>DAGENAIS, Gilles</snm><adr><str>670 Chemin des Oies,
St.-Nicholas</str><city>Quebec, J7A 3P8</city><ctry>CA</ctry></adr></B721><B721><snm>GERSTEIN, Hertzel</snm><adr><str>5 Dromore Crescent</str><city>Hamilton, Ontario L8S 4A8</city><ctry>CA</ctry></adr></B721><B721><snm>LJUNGGREN, Anders</snm><adr><str>Ringspinnaregatan 5</str><city>S-431 63 Mölndal</city><ctry>SE</ctry></adr></B721><B721><snm>YUSUF, Salim</snm><adr><str>48 Woodend Drive</str><city>Carlisle, Ontario L0R 1H2</city><ctry>CA</ctry></adr></B721></B720><B730><B731><snm>Sanofi-Aventis Deutschland GmbH</snm><iid>07118680</iid><adr><str>Brüningstrasse 50</str><city>65929 Frankfurt am Main</city><ctry>DE</ctry></adr></B731></B730></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>IE</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LU</ctry><ctry>MC</ctry><ctry>NL</ctry><ctry>PT</ctry><ctry>SE</ctry></B840><B844EP><B845EP><ctry>AL</ctry><date>20020909</date></B845EP><B845EP><ctry>LT</ctry><date>20020909</date></B845EP><B845EP><ctry>LV</ctry><date>20020909</date></B845EP><B845EP><ctry>MK</ctry><date>20020909</date></B845EP><B845EP><ctry>RO</ctry><date>20020909</date></B845EP><B845EP><ctry>SI</ctry><date>20020909</date></B845EP></B844EP><B860><B861><dnum><anum>EP2000008341</anum></dnum><date>20000825</date></B861><B862>en</B862></B860><B870><B871><dnum><pnum>WO2001015673</pnum></dnum><date>20010308</date><bnum>200110</bnum></B871></B870><B880><date>20020307</date><bnum>000000</bnum></B880></B800></SDOBI>
</ep-patent-document>
